AringerM, CostenbaderK, DaikhD. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis2019; 78: 1151–1159.
3.
SatohM, ChanEK, HoLA. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum2012; 64: 2319–27.
4.
ArnaudL, MertzP, GavandPE. Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database. Ann Rheum Dis2019; 78: 504–508.
5.
NisiharaR, PigossoYG, PradoN. Rheumatic disease autoantibodies in patients with autoimmune thyroid diseases. Med Princ Pract2018; 27: 332–336.
6.
YungRL, JohnsonKJ, RichardsonBC. New concepts in the pathogenesis of drug-induced lupus. Lab Invest1995; 73:746.
